Left-Ventricular Expression of lnterleukin-6 Messenger-RNA Higher in Idiopathic Dilated Than in Ischemic Cardiomyopathy

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The thoracic and cardiovascular surgeon

• Publication date

  1998-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2007-1010227PMID 9776495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery.

  1997cited by this paper
• Gp130 and the interleukin-6 family of cytokines.

  1997cited by this paper
• Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte*

  1997cited by this paper
• Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure.

  1996cited by this paper
• Elevated levels of interleukin-6 in unstable angina.

  1996cited by this paper
• Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  1996cited by this paper
• Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.

  1996cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.

  1996cited by this paper
• The Interdisciplinary Heart Failure and Transplant Program Münster: a 5-year experience.

  1995cited by this paper
• Hypoxic stress induces cardiac myocyte-derived interleukin-6.

  1995cited by this paper
• Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.

  1995cited by this paper
• Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury.

  1995cited by this paper
• Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.

  1995cited by this paper
• The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

  1995cited by this paper
• Cardiac release of cytokines and inflammatory responses in acute myocardial infarction.

  1995cited by this paper
• Local production of cytokines in the human cardiac allograft. A sequential study.

  1994cited by this paper
• Immune mechanisms of cardiac disease.

  1994cited by this paper
• Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

  1994cited by this paper
• The expression of acidic fibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells.

  1993cited by this paper
• Nitric oxide synthase activities in human myocardium.

  1993cited by this paper
• Interleukin-6 (IL-6) as a mediator of stunned myocardium.

  1993cited by this paper
• Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

  1992cited by this paper
• Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes.

  1988cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Emerging Roles of Ketone Bodies in Cardiac Fibrosis.

  2024cites this paper
• Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis.

  2023cites this paper
• EPHB2 knockdown mitigated MI-induced myocardial injury by inhibiting MAPK signaling

  2021cites this paper
• Subclinical Heart Dysfunction in Relation to Metabolic and Inflammatory Markers: a Community-Based Study.

  2020cites this paper
• Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue

  2020cites this paper
• Diverse origins and activation of fibroblasts in cardiac fibrosis.

  2020cites this paper
• Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.

  2019cites this paper
• Radiotherapy-induced heart disease: a review of the literature

  2019cites this paper
• Role of cytokines and inflammation in heart function during health and disease

  2018cites this paper
• A modern approach to interleukin-6

  2018cites this paper
• Anti-fibrotic Potential of AT2 Receptor Agonists

  2017cites this paper
• Effects of garlic oil on interleukin-6 mediated cardiac hypertrophy in hypercholesterol-fed hamsters.

  2017cites this paper
• Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.

  2016cites this paper
• The varying faces of IL-6: From cardiac protection to cardiac failure.

  2015influential citation
• Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy

  2012cites this paper
• Cardiac remodeling and diastolic dysfunction in DahlS.Z-Leprfa/Leprfa rats: a new animal model of metabolic syndrome

  2012cites this paper
• Biocompatibility and Gene Expression Associated with Streptococcus Infection in Myocarditis

  2012cites this paper
• Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy.

  2011cites this paper
• Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

  2009cites this paper
• Myocardial pro-inflammatory cytokine expression and cellular rejection in pediatric heart transplant recipients.

  2008cites this paper
• Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.

  2007cites this paper
• Can the Protective Actions of JAK-STAT in the Heart be Exploited Therapeutically? Parsing the Regulation of Interleukin-6-Type Cytokine Signaling

  2007cites this paper
• Soluble Tumor Necrosis Factor Receptor Type I and Dranulysin as Immunological Markers in Congestive Heart Failure

  2005cites this paper
• Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

  2004cites this paper
• Interleukin-6 and cardiovascular diseases.

  2004cites this paper
• Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children.

  2003cites this paper
• The interleukin-6/interleukin-6-receptor system is activated in donor hearts.

  2002cites this paper
• Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6

  2002cites this paper
• Predictors of Allograft Ischemic Injury in Clinical Heart Transplantation

  2002cites this paper
• Biomarkers and Exercise Training: A Possible Missing Link between Physical Activity and Mortality Benefit in Patients with Heart Failure

  2001cites this paper
• Quantitative Myocardial Cytokine Expression and Activation of the Apoptotic Pathway in Patients Who Require Left Ventricular Assist Devices

  2001cites this paper
• Activation of the cardiac interleukin-6 system in advanced heart failure.

  2001cites this paper
• Activation of the cardiac interleukin‐6 system in advanced heart failure

  2001cites this paper
• Myocardial gene expression of leukaemia inhibitory factor, interleukin‐6 and glycoprotein 130 in end‐stage human heart failure

  2001cites this paper
• Insights into pathogenesis and treatment of cytokines in cardiomyopathy

  2000cites this paper
• Reversal of myocardial interleukin-6-mRNA expression following long-term left ventricular assist device support for myocarditis-associated low output syndrome.

  1999cites this paper
• Left Ventricular Assist System Support Is Associated With Persistent Inflammation and Temporary Immunosuppression

  1999cites this paper
• Cellular and Molecular Life Sciences the Pathogenesis of Cardiac Fibrosis

  year unknowncites this paper